Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Buy
93,600
+11,000
+13% +$1.99M 0.12% 140
2026
Q1
$12.2M Buy
+82,600
New +$13.4M 0.09% 152
2024
Q4
– Sell
-10,000
Closed -$1.7M – 2203
2024
Q3
$1.7M Hold
10,000
– – 0.03% 533
2024
Q2
$1.41M Buy
10,000
+9,000
+900% +$1.12M 0.02% 599
2024
Q1
$126K Sell
1,000
-21,500
-96% -$2.46M ﹤0.01% 1571
2023
Q4
$2.37M Sell
22,500
-12,500
-36% -$1.36M 0.06% 305
2023
Q3
$3.71M Buy
+35,000
New +$4.05M 0.08% 221
2023
Q2
– Sell
-29,300
Closed -$2.72M – 1893
2023
Q1
$2.72M Buy
29,300
+27,500
+1,528% +$2.41M 0.07% 315
2022
Q4
$147K Buy
+1,800
New +$137K ﹤0.01% 1134
2022
Q1
– Sell
-25,000
Closed -$2.18M – 1748
2021
Q4
$2.18M Buy
+25,000
New +$2.35M 0.05% 348
2021
Q1
– Sell
-30,000
Closed -$1.94M – 1360
2020
Q4
$1.94M Buy
+30,000
New +$1.79M 0.08% 154
2019
Q2
– Sell
-31,900
Closed -$1.71M – 490
2019
Q1
$1.71M Buy
+31,900
New +$1.63M 0.12% 126

Other funds holding ORCL

Centiva Capital's ORCL Position: Q2 2026 in Review

Centiva Capital reduced its Oracle (ORCL) stake by 29% in Q2 2026, selling an estimated $1.61M and leaving 21,843 shares worth $3.2M. The position accounts for 0.03% of the portfolio, ranked #344.

Centiva Capital first reported a position in ORCL in Q1 2019 and has held it in 23 quarters since. The position peaked at $6.49M in Q3 2020. 3,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Centiva Capital held 21,843 shares of Oracle worth $3.2M as of Q2 2026.
  • Centiva Capital sold 8,875 Oracle shares in Q2 2026, an estimated $1.61M.
  • Oracle made up 0.03% of Centiva Capital's portfolio in Q2 2026, its #344 holding.
  • Centiva Capital first reported a position in Oracle in Q1 2019 and has held it in 23 quarters since.
  • Centiva Capital's Oracle position peaked at $6.49M in Q3 2020.
  • 3,537 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.